In chronic myelogenous leukemia (CML), curcumin was found to up-regulate the expression of miR-22 and down-regulate its target gene importin 7 (IPO7), thus affecting the nuclear transport of HIF-1α [226]. The gene discussed is HIF1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.